In vitro test for the quantitative determination of the catalytic activity of GGT (EC 2.3.2.2, c-gloutamylopeptid: c-gloutamylotanaferasi amino acid) in human serum and plasma.
For Integra 400.
Every package includes 400 assays.
In vitro test for the quantitative determination of the catalytic activity of GGT (EC 2.3.2.2, c-gloutamylopeptid: c-gloutamylotanaferasi amino acid) in human serum and plasma.
For Integra 400.
Every package includes 400 assays.
Αναλυτής | |
---|---|
COMPANY | |
Συσκευασία | |
SECTION |
CLINICAL CHEMISTRY
The activator is a utility maintenance reagent consists in daily maintenance tasks to prepare the electrodes, tubing and [...]
CLINICAL CHEMISTRY
In vitro test for the quantitative determination of calcium in serum, human plasma and urine. For Integra 400. [...]
CLINICAL CHEMISTRY
In vitro test for the quantification of direct bilirubin in human serum and plasma in Roche / Hitachi [...]
CLINICAL CHEMISTRY
Automated systems calibrator (C.f.a.s.) is intended for use to calibrate Roche’s quantitative methods on clinical chemistry analyzers. Package [...]
CLINICAL CHEMISTRY
C.f.a.s. Lipids is intended to be used for calibrating the quantitative methods on cobas c 111 analyzer. Package [...]
CLINICAL CHEMISTRY
In vitro test for the quantitative determination of albumin in serum and human plasma. For cobas c 111. [...]